PDS Biotechnology Files 8-K
Ticker: PDSB · Form: 8-K · Filed: Sep 18, 2025 · CIK: 1472091
| Field | Detail |
|---|---|
| Company | Pds Biotechnology Corp (PDSB) |
| Form Type | 8-K |
| Filed Date | Sep 18, 2025 |
| Risk Level | low |
| Pages | 2 |
| Reading Time | 2 min |
| Key Dollar Amounts | $0.00033 |
| Sentiment | neutral |
Sentiment: neutral
Topics: corporate-filing, 8-K, biotechnology
TL;DR
PDS Biotech filed an 8-K on 9/18/25, standard corporate update.
AI Summary
PDS Biotechnology Corporation filed an 8-K on September 18, 2025, reporting on other events and financial statements. The company, incorporated in Delaware, is based in Princeton, NJ, and operates in the Pharmaceutical Preparations sector. Previously known as Edge Therapeutics, Inc., the company changed its name on September 11, 2009.
Why It Matters
This filing indicates routine corporate reporting for PDS Biotechnology, providing updates on significant events and financial disclosures to investors and the SEC.
Risk Assessment
Risk Level: low — This filing is a routine 8-K for corporate events and financial statements, not indicating any specific new risks.
Key Numbers
- 001-37568 — SEC File Number (Identifies the company's filing history with the SEC.)
- 26-4231384 — I.R.S. Employer Identification No. (Company's tax identification number.)
Key Players & Entities
- PDS Biotechnology Corporation (company) — Registrant
- September 18, 2025 (date) — Date of Report
- Delaware (jurisdiction) — State of Incorporation
- Princeton, NJ (location) — Principal Executive Offices
- Edge Therapeutics, Inc. (company) — Former Company Name
- September 11, 2009 (date) — Date of Name Change
FAQ
What specific events are being reported in this 8-K filing?
The filing indicates it covers 'Other Events' and 'Financial Statements and Exhibits'.
When was PDS Biotechnology Corporation incorporated?
The company was incorporated in Delaware.
What was the previous name of PDS Biotechnology Corporation?
The company was formerly known as Edge Therapeutics, Inc.
Where are PDS Biotechnology Corporation's principal executive offices located?
The principal executive offices are located at 303A College Road East, Princeton, NJ 08540.
What is the SIC code for PDS Biotechnology Corporation?
The Standard Industrial Classification code is 2834, which corresponds to Pharmaceutical Preparations.
Filing Stats: 454 words · 2 min read · ~2 pages · Grade level 10.6 · Accepted 2025-09-18 08:50:52
Key Financial Figures
- $0.00033 — ch registered Common Stock, par value $0.00033 per share PDSB The Nasdaq Capital M
Filing Documents
- ef20055698_8k.htm (8-K) — 28KB
- ef20055698_ex99-1.htm (EX-99.1) — 20KB
- image00001.jpg (GRAPHIC) — 3KB
- 0001140361-25-035339.txt ( ) — 183KB
- pdsb-20250918.xsd (EX-101.SCH) — 4KB
- pdsb-20250918_lab.xml (EX-101.LAB) — 21KB
- pdsb-20250918_pre.xml (EX-101.PRE) — 16KB
- ef20055698_8k_htm.xml (XML) — 4KB
01
Item 8.01 Other Events. On September 18, 2025, PDS Biotechnology Corporation issued a press release announcing details of a sub-analysis of the cohort of patients with low PD-L1 expression (CPS 1-19) from the final data for its recently completed VERSATILE-002 Phase 2 clinical trial. A copy of the press release is filed herewith as Exhibit 99.1 and incorporated by reference herein.
Financial Statements and Exhibits
Financial Statements and Exhibits. (d) Exhibits. Exhibit Number Description 99.1 Press Release Dated September 18, 2025. 104 Cover Page Interactive Data File (embedded within the Inline XBRL Document). Signature Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. PDS BIOTECHNOLOGY CORPORATION Date: September 18, 2025 By: /s/ Frank Bedu-Addo, Ph.D. Name: Frank Bedu-Addo, Ph.D. Title: President and Chief Executive Officer